Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Delayed Nyse Other stock markets 10:30:02 03/07/2024 pm IST			5-day change	1st Jan Change
126.1 ^USD	+0.28%		-5.23%	-9.28%

02/07	Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	MT
01/07	Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary	CI

Agilent Technologies : to Present at 34th Annual J.P. Morgan Healthcare Conference

January 06, 2016 at 01:16 am IST

Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community:

34^th Annual J.P. Morgan Healthcare Conference
Westin St. Francis Hotel, San Francisco, California
Tuesday, Jan. 12, 2016, at 10 a.m. (PT)
Mike McMullen, Agilent president and chief executive officer

A link to the webcast will be available at www.investor.agilent.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at http://www.agilent.com/go/news.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160105006550/en/

Latest news about Agilent Technologies, Inc.

Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	02/07	MT
Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000 Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000E Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index	01/07	CI
Wolfe Research Downgrades Agilent Technologies to Peer Perform From Outperform	27/06	MT
RareCyte, Inc. announced that it has received $20 million in funding from a group of investors	27/06	CI
Masimo Shareholder Politan Capital Campaigns for 2 More Board Seats	26/06	MT
Bristol Myers: ex-CEO of Agilent joins Board of Directors	19/06	CF
MGI Tech Co., Ltd. and SeqOne Partner to Advance End-To-End Genomic Analysis	17/06	CI
Agilent Technologies Insider Sold Shares Worth $1,999,262, According to a Recent SEC Filing	12/06	MT
Agilent Technologies Insider Sold Shares Worth $254,540, According to a Recent SEC Filing	05/06	MT
Agilent Technologies Seeks M&A	05/06	CI
Transcript : Agilent Technologies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 08:30 AM	05/06
Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics	03/06	CI
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	03/06	CI
A new phase for the market	30/05
UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	30/05	MT
Wolfe Research Adjusts Agilent Technologies' PT to $135 From $155	30/05	MT
Leerink Adjusts Price Target on Agilent Technologies to $135 From $150	30/05	MT
Stifel Adjusts Price Target on Agilent Technologies to $151 From $163	30/05	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $165	30/05	MT
Bernstein Adjusts Price Target on Agilent Technologies to $125 From $130	30/05	MT
TD Cowen Adjusts Price Target on Agilent Technologies to $153 From $163	30/05	MT

Chart Agilent Technologies, Inc.

Duration

Period

More charts

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

18/11/2024 - Q4 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Agilent Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

126.1 USD

Average target price

140.1 USD

Spread / Average Target

+11.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AGILENT TECHNOLOGIES, INC.	-9.28%	3.68TCr
THERMO FISHER SCIENTIFIC	+0.91%	20TCr
DANAHER CORPORATION	+3.74%	18TCr
INTUITIVE SURGICAL, INC.	+28.89%	15TCr
BOSTON SCIENTIFIC CORPORATION	+31.66%	11TCr
SIEMENS HEALTHINEERS AG	+1.56%	6.42TCr
EDWARDS LIFESCIENCES CORPORATION	+19.45%	5.49TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.44%	4.67TCr
GE HEALTHCARE TECHNOLOGIES INC.	-0.10%	3.53TCr
RESMED, INC.	+10.10%	2.78TCr

Other Advanced Medical Equipment & Technology